Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients
Open Access
- 10 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 819724
Abstract
Pancreatic cancer (PC) is one of the most lethal malignancies, the mortality and morbidity of which have been increasing over the past decade. Ferroptosis, a newly identified iron-dependent cell death pattern, can be induced by iron chelators and small lipophilic antioxidants. Nonetheless, the prognostic significance of ferroptosis-related lncRNAs in PC remains to be clarified. We obtained the lncRNA expression matrix and clinicopathological information of PC patients from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) datasets in the current study. Firstly, we conducted Pearson correlation analysis to delve into the ferroptosis-related lncRNAs, and univariate Cox analysis was implemented to examine the prognostic values in PC patients. Twenty-three prognostic ferroptosis-related lncRNAs were confirmed and loaded into the least absolute shrinkage and selection operator Cox (LASSO-Cox) analysis, then a ferroptosis-related lncRNA prognostic marker (Fe-LPM) was established in the TCGA dataset. Risk scores of patients were calculated and segregated PC patients into low-risk and high-risk subgroups in each dataset. The prognostic capability of Fe-LPM was also confirmed in the ICGC dataset. Gene set enrichment analysis (GSEA) revealed that several ferroptosis-related pathways were enriched in low-risk subgroups. Furthermore, we adopted a multivariate Cox regression to establish a nomogram based on risk score, age, pathological T stage and primary therapy outcome. A competing endogenous RNA (ceRNA) network was also created relied on four of the twenty-three ferroptosis-related lncRNAs. In conclusion, the eight Fe-LPM can be utilized to anticipate the overall survival (OS) of PC patients, which are meaningful to guiding clinical strategies in PC.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81873589)
- Natural Science Foundation of Hunan Province
- Science and Technology Bureau, Changsha
This publication has 38 references indexed in Scilit:
- New Insights into Long Non-Coding RNA MALAT1 in Cancer and MetastasisCancers, 2019
- A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53Cancer Research, 2018
- Therapeutic developments in pancreatic cancer: current and future perspectivesNature Reviews Gastroenterology & Hepatology, 2018
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancerCancer Letters, 2017
- The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1Nature Cell Biology, 2017
- Pancreatic cancer models for translational researchPharmacology & Therapeutics, 2017
- Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic DevelopmentClinical Cancer Research, 2017
- Recent progress in pancreatic cancerCA: A Cancer Journal for Clinicians, 2013
- Pancreatic cancerThe Lancet, 2011